For example, one study published in Lancet Neurology focused on the role of cerebrospinal fluid hypocretin measurement in diagnosing narcolepsy and hypersomnias, providing insights into how similar biomarkers could be applied to sleep disorders in PD (Bourgin et al., 2008). The gene discussed is HCRT; the disease is narcolepsy.